C20ORF194 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.62447832963153E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.13370424159598E-11 |
Normal-vs-Stage2 |
7.68160002273532E-09 |
Normal-vs-Stage3 |
<1E-12 |
Normal-vs-Stage4 |
1.62436730732907E-12 |
Stage1-vs-Stage2 |
2.256800E-01 |
Stage1-vs-Stage3 |
2.37300000005547E-06 |
Stage1-vs-Stage4 |
3.56730000000693E-05 |
Stage2-vs-Stage3 |
4.829600E-02 |
Stage2-vs-Stage4 |
2.942000E-02 |
Stage3-vs-Stage4 |
6.441000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.62447832963153E-12 |
Normal-vs-AfricanAmerican |
5.68829999999521E-05 |
Normal-vs-Asian |
2.190800E-01 |
Caucasian-vs-AfricanAmerican |
3.234100E-02 |
Caucasian-vs-Asian |
1.935790E-01 |
AfricanAmerican-vs-Asian |
7.197400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
<1E-12 |
Normal-vs-Female |
9.11404285375284E-12 |
Male-vs-Female |
5.158200E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.97742999999972E-05 |
Normal-vs-Age(41-60Yrs) |
8.33777491493493E-14 |
Normal-vs-Age(61-80Yrs) |
<1E-12 |
Normal-vs-Age(81-100Yrs) |
9.73260000000087E-05 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.327000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.186400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.561000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.498400E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.244800E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.583600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
3.656600E-01 |
Normal-vs-Grade 2 |
1.44489975539841E-11 |
Normal-vs-Grade 3 |
1.62447832963153E-12 |
Normal-vs-Grade 4 |
1.62447832963153E-12 |
Grade 1-vs-Grade 2 |
5.427500E-04 |
Grade 1-vs-Grade 3 |
2.99000000314464E-08 |
Grade 1-vs-Grade 4 |
8.86659967669345E-10 |
Grade 2-vs-Grade 3 |
1.210480E-04 |
Grade 2-vs-Grade 4 |
1.02859999961957E-07 |
Grade 3-vs-Grade 4 |
1.438030E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
7.06199987376976E-10 |
Normal-vs-ccB subtype |
1.62436730732907E-12 |
ccA subtype-vs-ccB subtype |
7.46670000273397E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.62569957495862E-12 |
Normal-vs-N1 |
4.16290335536473E-11 |
N0-vs-N1 |
2.496500E-02 |
|
|